•
Sep 30, 2020

Bausch Health Q3 2020 Earnings Report

Third quarter results demonstrated recovery from the COVID-19 pandemic.

Key Takeaways

Bausch Health's third-quarter 2020 results demonstrated recovery from the COVID-19 pandemic with total company reported revenue growing 28% sequentially from the second quarter. The company reaffirmed its 2020 full-year revenue and adjusted EBITDA guidance ranges.

Revenues of $2.138 Billion

GAAP Net Income of $71 Million

Adjusted EBITDA (non-GAAP) of $948 Million

GAAP Cash Generated from Operations of $256 Million

Total Revenue
$2.14B
Previous year: $2.21B
-3.2%
EPS
$1.32
Previous year: $1.19
+10.9%
Adjusted EBITDA
$948M
Previous year: $942M
+0.6%
Cash from Operations
$256M
Previous year: $515M
-50.3%
Gross Profit
$1.55B
Previous year: $1.63B
-4.7%
Cash and Equivalents
$977M
Previous year: $825M
+18.4%
Free Cash Flow
$175M
Previous year: $432M
-59.5%
Total Assets
$31.6B
Previous year: $31.7B
-0.3%

Bausch Health

Bausch Health

Bausch Health Revenue by Segment

Forward Guidance

Bausch Health reaffirmed its revenue and Adjusted EBITDA guidance ranges for the full year of 2020, reflecting management’s current expectations.

Revenue & Expenses

Visualization of income flow from segment revenue to net income